E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 870 KRW 0.51% Market Closed
Market Cap: ₩435B

Net Margin

31.9%
Current
Improving
by 29.6%
vs 3-y average of 2.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
31.9%
=
Net Income
₩49.1B
/
Revenue
₩153.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
31.9%
=
Net Income
₩49.1B
/
Revenue
₩153.7B

Peer Comparison

Country Company Market Cap Net
Margin
KR
EuBiologics Co Ltd
KOSDAQ:206650
434.7B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
391.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.9B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 96% of companies in Korea
Percentile
96th
Based on 2 632 companies
96th percentile
31.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

EuBiologics Co Ltd
Glance View

Market Cap
435B KRW
Industry
Biotechnology

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

EuBiologics Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
31.9%
=
Net Income
₩49.1B
/
Revenue
₩153.7B
What is EuBiologics Co Ltd's current Net Margin?

The current Net Margin for EuBiologics Co Ltd is 31.9%, which is above its 3-year median of 2.4%.

How has Net Margin changed over time?

Over the last 3 years, EuBiologics Co Ltd’s Net Margin has increased from -0.7% to 31.9%. During this period, it reached a low of -34.2% on Jun 30, 2024 and a high of 32.1% on Jun 30, 2025.

Back to Top